Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates myocardial ischemia/reperfusion injury in a rat model.
about
Hesperidin produces cardioprotective activity via PPAR-γ pathway in ischemic heart disease model in diabetic ratsCiglitazone ameliorates lung inflammation by modulating the inhibitor kappaB protein kinase/nuclear factor-kappaB pathway after hemorrhagic shockEffects of PPARalpha on cardiac glucose metabolism: a transcriptional equivalent of the glucose-fatty acid cycle?TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection.Cardiac remodeling in obesity.Vasculoprotective effects of rosiglitazone through modulating renin-angiotensin system in vivo and vitroSerum levels of the MCP-1 chemokine in patients with ischemic stroke and myocardial infarction.Maraviroc attenuates trauma-hemorrhage-induced hepatic injury through PPAR gamma-dependent pathway in ratsPharmacogenomics and pharmacogenetics of thiazolidinediones: role in diabetes and cardiovascular risk factors.Insulinotropic and anti-inflammatory effects of rosiglitazone in experimental autoimmune diabetes.Peroxisome proliferator-activated receptor ligands in atherosclerosis.Peroxisome Proliferator-Activated Receptors and the Heart: Lessons from the Past and Future Directions.Molecular defects in cardiac myofibrillar proteins due to thyroid hormone imbalance and diabetes.Diabetes, perioperative ischaemia and volatile anaesthetics: consequences of derangements in myocardial substrate metabolism.PPAR-gamma activation fails to provide myocardial protection in ischemia and reperfusion in pigs.To Live or to Die: Prosurvival Activity of PPARgamma in Cancers.Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists.The possible role of peroxisome proliferator-activated receptor gamma in heart failure.PPARs as therapeutic targets in cardiovascular disease.The potential effects of anti-diabetic medications on myocardial ischemia-reperfusion injury.Therapeutic Potential of PPARγ Activation in Stroke.Peroxisome proliferator-activated receptor agonists modulate neuropathic pain: a link to chemokines?Role of Pleiotropic Properties of Peroxisome Proliferator-Activated Receptors in the Heart: Focus on the Nonmetabolic Effects in Cardiac Protection.Downregulation of microRNA-29 by antisense inhibitors and a PPAR-gamma agonist protects against myocardial ischaemia-reperfusion injury.Telmisartan, an angiotensin-II receptor blocker ameliorates cardiac remodeling in rats with dilated cardiomyopathy.Antidiabetic drug pioglitazone protects the heart via activation of PPAR-gamma receptors, PI3-kinase, Akt, and eNOS pathway in a rabbit model of myocardial infarction.Pioglitazone protects the myocardium against ischemia-reperfusion injury in eNOS and iNOS knockout mice.Myocardial Expression of PPARγ and Exercise Capacity in Patients after Coronary Artery Bypass Surgery.Pioglitazone limits myocardial infarct size, activates Akt, and upregulates cPLA2 and COX-2 in a PPAR-γ-independent manner.Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.In-vivo antioxidant and anti-inflammatory activity of rosiglitazone, a peroxisome proliferator-activated receptor-gamma (PPAR-γ) agonists in animal model of bronchial asthma.Apigenin Attenuates β-Receptor-Stimulated Myocardial Injury Via Safeguarding Cardiac Functions and Escalation of Antioxidant Defence System.Effect of Hexadecyl Azelaoyl Phosphatidylcholine on Cardiomyocyte Apoptosis in Myocardial Ischemia-Reperfusion Injury: A Hypothesis.
P2860
Q28544702-A0D5F48D-003A-4CFB-B43C-0B9B39869B67Q28575608-94323188-A3AC-48D6-AAB4-4C026198C022Q30353176-B42F48C4-7A4B-41C9-9767-6903CC45F5C5Q30375496-6AC3FDB9-829C-4DE7-8FFA-DA04EBE67844Q34043589-B6744921-297F-47F6-819F-C404A5EAFBDBQ34576530-808CB72B-2615-4DEA-8F0F-A308E31FF476Q34894419-65F7343C-B64E-470C-B834-16A2E9EB232AQ35036778-36DC9214-CE4C-4992-83E0-785C85F37953Q35039274-CD8BFDEB-9DB7-4626-89E7-676A1D480112Q35612704-F8B8AE3F-FD1B-4018-953D-F182613F5BC8Q35925566-521E5773-0E52-4DF0-AF00-C821DDD9E231Q36261125-F3DF29C0-8C65-4AC2-B30D-33831B4F64A8Q36389347-82BC749B-0AD2-47A7-ACDD-5485BB2DF80AQ36689230-2BF7B5EF-0AC2-4A3A-983B-1705C72FAEB6Q36787677-981FB0ED-9D3F-4388-922B-A7859014ACA7Q36867693-A564371A-737A-4238-B496-117CCE774446Q36992256-BC3DE29D-8222-4FCD-B1B1-12678695D431Q37277818-33C3B32D-1B12-44F6-87AE-2E1D6C12961AQ37790384-7B444078-2961-42A0-A67F-1FCD2C9F3C2AQ37926558-05FA481B-3122-4BCE-B6A5-70D3F1B532C2Q37930425-40E6C33C-57BF-4C51-87A5-5CB901945C7EQ38246264-55518BD7-8231-47BB-8F1D-6964CA18A592Q38640842-29915E5F-D23A-4D2A-9451-92005AD6DCE2Q39738140-8B0D0A6F-C269-4999-95BD-BE2A67524CECQ43036719-13373C6D-50C3-41C6-A200-62DF10AA333DQ46087968-44176434-420C-4C09-80DE-5ED2493321F1Q46309781-67209492-1C33-42AB-A566-7054594C7055Q47152359-AB8988D2-552C-49B2-BFDB-B826644B6345Q47388835-AF7B3F49-CB79-4462-A5D6-2ADFCACD14BBQ48617615-1B816DFA-5D7F-4E49-A0E8-67114E5173FCQ53201459-2E1F2D21-C6B1-41E2-9759-07111F5C615CQ53420523-5F71F873-22A9-4712-AF69-370B4DC6AF15Q55417016-2171D327-3DC0-4331-A3F5-95AEB5088605
P2860
Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates myocardial ischemia/reperfusion injury in a rat model.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Pioglitazone, a peroxisome pro ...... rfusion injury in a rat model.
@en
Pioglitazone, a peroxisome pro ...... rfusion injury in a rat model.
@nl
type
label
Pioglitazone, a peroxisome pro ...... rfusion injury in a rat model.
@en
Pioglitazone, a peroxisome pro ...... rfusion injury in a rat model.
@nl
prefLabel
Pioglitazone, a peroxisome pro ...... rfusion injury in a rat model.
@en
Pioglitazone, a peroxisome pro ...... rfusion injury in a rat model.
@nl
P2093
P2860
P1476
Pioglitazone, a peroxisome pro ...... rfusion injury in a rat model.
@en
P2093
Akira Matsumori
Atsushi Nakano
Haruyasu Ito
Makoto Kinoshita
P2860
P304
P356
10.1097/01.LAB.0000106724.29121.DA
P577
2003-12-01T00:00:00Z
P6179
1051200458